Skip to main content
. 2023 May 21;12(5):936. doi: 10.3390/antibiotics12050936

Table 4.

Treatment strategy and all-cause mortality.

Treatment Number of Patients 14-Day All-Cause Mortality 28-Day All-Cause Mortality Organisms (Number of Cases)
Combination therapy with cefiderocol 10 0 (0%) 0 (0%) DTR-P (4)
CRAB (6)
Cefiderocol monotherapy 12 1 (8.3%) 3 (25%) DTR-P (10)
CRAB (2)
p value 1.0 0.25